WallStreetZenWallStreetZen

NASDAQ: IMCR
Immunocore Holdings PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IMCR

Based on 6 analysts offering 12 month price targets for Immunocore Holdings PLC

Min Forecast
$33.00+8.16%
Avg Forecast
$59.83+96.11%
Max Forecast
$100.00+227.76%

Should I buy or sell IMCR stock?

Based on 6 analysts offering ratings for Immunocore Holdings PLC.

Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IMCR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates IMCR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their IMCR stock forecasts and price targets.

IMCR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-16
lockedlocked$00.00+00.00%2026-02-26
lockedlocked$00.00+00.00%2026-02-04
lockedlocked$00.00+00.00%2026-01-07Find Out Why
lockedlocked$00.00+00.00%2025-11-10
Wells Fargo
Top 11%
90
Strong BuyInitiates Coverage On$60.00+96.66%2025-10-31

1 of 1

Forecast return on equity

Is IMCR forecast to generate an efficient return?

Company
39.78%
Industry
62.84%
Market
179.06%
IMCR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMCR forecast to generate an efficient return on assets?

Company
14.2%
Industry
31.64%
IMCR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMCR earnings per share forecast

What is IMCR's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
-$1.08
Avg 2 year Forecast
-$1.26
Avg 3 year Forecast
$0.65

IMCR revenue forecast

What is IMCR's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$458.3M+14.57%
Avg 2 year Forecast
$495.9M+23.97%
Avg 3 year Forecast
$588.0M+47%
IMCR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMCR revenue growth forecast

How is IMCR forecast to perform vs Biotechnology companies and vs the US market?

Company
12.94%
Industry
35.08%
Market
13.19%
IMCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMCR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMCR$30.51$59.83+96.11%Buy
DMRA$25.63$44.25+72.65%Strong Buy
NUVB$4.42$11.38+157.35%Strong Buy
NTLA$13.24$20.91+57.90%Buy
VCEL$30.82$54.50+76.83%Strong Buy
View Top Biotech Stocks

Immunocore Holdings Stock Forecast FAQ

Is Immunocore Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: IMCR) stock is to Buy IMCR stock.

Out of 6 analysts, 2 (33.33%) are recommending IMCR as a Strong Buy, 2 (33.33%) are recommending IMCR as a Buy, 2 (33.33%) are recommending IMCR as a Hold, 0 (0%) are recommending IMCR as a Sell, and 0 (0%) are recommending IMCR as a Strong Sell.

If you're new to stock investing, here's how to buy Immunocore Holdings stock.

What is IMCR's earnings growth forecast for 2026-2028?

(NASDAQ: IMCR) Immunocore Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.89%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.94%.

Immunocore Holdings's earnings in 2026 is -$35,514,000.On average, 19 Wall Street analysts forecast IMCR's earnings for 2026 to be -$54,578,321, with the lowest IMCR earnings forecast at -$117,110,700, and the highest IMCR earnings forecast at -$17,033,546. On average, 18 Wall Street analysts forecast IMCR's earnings for 2027 to be -$63,855,520, with the lowest IMCR earnings forecast at -$194,253,400, and the highest IMCR earnings forecast at $49,503,744.

In 2028, IMCR is forecast to generate $33,002,496 in earnings, with the lowest earnings forecast at -$151,527,588 and the highest earnings forecast at $218,242,311.

What is IMCR's revenue growth forecast for 2026-2028?

(NASDAQ: IMCR) Immunocore Holdings's forecast annual revenue growth rate of 12.94% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.19%.

Immunocore Holdings's revenue in 2026 is $400,016,000.On average, 20 Wall Street analysts forecast IMCR's revenue for 2026 to be $23,233,554,247, with the lowest IMCR revenue forecast at $21,455,170,911, and the highest IMCR revenue forecast at $25,922,928,135. On average, 19 Wall Street analysts forecast IMCR's revenue for 2027 to be $25,140,196,131, with the lowest IMCR revenue forecast at $17,165,860,362, and the highest IMCR revenue forecast at $31,986,059,464.

In 2028, IMCR is forecast to generate $29,810,226,716 in revenue, with the lowest revenue forecast at $15,364,664,240 and the highest revenue forecast at $45,006,076,347.

What is IMCR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: IMCR) forecast ROA is 14.2%, which is lower than the forecast US Biotechnology industry average of 31.64%.

What is IMCR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IMCR price target, the average IMCR price target is $59.83, with the highest IMCR stock price forecast at $100.00 and the lowest IMCR stock price forecast at $33.00.

On average, Wall Street analysts predict that Immunocore Holdings's share price could reach $59.83 by Mar 16, 2027. The average Immunocore Holdings stock price prediction forecasts a potential upside of 96.11% from the current IMCR share price of $30.51.

What is IMCR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IMCR) Immunocore Holdings's current Earnings Per Share (EPS) is -$0.71. On average, analysts forecast that IMCR's EPS will be -$1.08 for 2026, with the lowest EPS forecast at -$2.31, and the highest EPS forecast at -$0.34. On average, analysts forecast that IMCR's EPS will be -$1.26 for 2027, with the lowest EPS forecast at -$3.83, and the highest EPS forecast at $0.98. In 2028, IMCR's EPS is forecast to hit $0.65 (min: -$2.99, max: $4.31).

What is IMCR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: IMCR) forecast ROE is 39.78%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.